vs

Side-by-side financial comparison of SIERRA BANCORP (BSRR) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

SIERRA BANCORP is the larger business by last-quarter revenue ($39.3M vs $34.2M, roughly 1.1× PRECISION BIOSCIENCES INC). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs 40.4%, a 18.5% gap on every dollar of revenue. On growth, PRECISION BIOSCIENCES INC posted the faster year-over-year revenue change (5261.1% vs 3.8%). SIERRA BANCORP produced more free cash flow last quarter ($32.2M vs $-11.3M). Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs 2.6%).

Sierra Bancorp is a U.S.-based regional bank holding company operating the Bank of the Sierra brand. It offers full retail and commercial banking services including deposit products, consumer and commercial loans, and mortgages, primarily serving local communities, SMEs and individual customers across Central and Southern California.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

BSRR vs DTIL — Head-to-Head

Bigger by revenue
BSRR
BSRR
1.1× larger
BSRR
$39.3M
$34.2M
DTIL
Growing faster (revenue YoY)
DTIL
DTIL
+5257.4% gap
DTIL
5261.1%
3.8%
BSRR
Higher net margin
DTIL
DTIL
18.5% more per $
DTIL
58.9%
40.4%
BSRR
More free cash flow
BSRR
BSRR
$43.4M more FCF
BSRR
$32.2M
$-11.3M
DTIL
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
2.6%
BSRR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BSRR
BSRR
DTIL
DTIL
Revenue
$39.3M
$34.2M
Net Profit
$12.9M
$20.1M
Gross Margin
Operating Margin
43.6%
36.6%
Net Margin
40.4%
58.9%
Revenue YoY
3.8%
5261.1%
Net Profit YoY
24.4%
213.5%
EPS (diluted)
$0.96
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BSRR
BSRR
DTIL
DTIL
Q4 25
$39.3M
$34.2M
Q3 25
$40.0M
$13.0K
Q2 25
$39.2M
$18.0K
Q1 25
$36.8M
$29.0K
Q4 24
$37.9M
$638.0K
Q3 24
$38.6M
$576.0K
Q2 24
$37.8M
$49.9M
Q1 24
$37.3M
$17.6M
Net Profit
BSRR
BSRR
DTIL
DTIL
Q4 25
$12.9M
$20.1M
Q3 25
$9.7M
$-21.8M
Q2 25
$10.6M
$-23.5M
Q1 25
$9.1M
$-20.6M
Q4 24
$10.4M
Q3 24
$10.6M
$-16.4M
Q2 24
$10.3M
$32.7M
Q1 24
$9.3M
$8.6M
Operating Margin
BSRR
BSRR
DTIL
DTIL
Q4 25
43.6%
36.6%
Q3 25
31.7%
-158976.9%
Q2 25
36.3%
-121538.9%
Q1 25
33.4%
-76248.3%
Q4 24
33.3%
Q3 24
37.4%
-3693.6%
Q2 24
37.6%
48.4%
Q1 24
33.9%
-23.8%
Net Margin
BSRR
BSRR
DTIL
DTIL
Q4 25
40.4%
58.9%
Q3 25
24.2%
-167476.9%
Q2 25
27.1%
-130666.7%
Q1 25
24.8%
-70913.8%
Q4 24
34.1%
Q3 24
27.5%
-2851.6%
Q2 24
27.2%
65.6%
Q1 24
25.0%
48.8%
EPS (diluted)
BSRR
BSRR
DTIL
DTIL
Q4 25
$0.96
$2.62
Q3 25
$0.72
$-1.84
Q2 25
$0.78
$-2.13
Q1 25
$0.65
$-2.21
Q4 24
$0.73
Q3 24
$0.74
$-2.25
Q2 24
$0.71
$4.67
Q1 24
$0.64
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BSRR
BSRR
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$135.6M
$115.6M
Total DebtLower is stronger
$49.5M
Stockholders' EquityBook value
$364.9M
$92.2M
Total Assets
$3.8B
$154.4M
Debt / EquityLower = less leverage
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BSRR
BSRR
DTIL
DTIL
Q4 25
$135.6M
$115.6M
Q3 25
$95.5M
$44.9M
Q2 25
$130.0M
$62.2M
Q1 25
$159.7M
$77.2M
Q4 24
$100.7M
$86.3M
Q3 24
$132.8M
$101.2M
Q2 24
$184.0M
$123.6M
Q1 24
$119.2M
$137.8M
Total Debt
BSRR
BSRR
DTIL
DTIL
Q4 25
$49.5M
Q3 25
$49.5M
Q2 25
$49.4M
Q1 25
$49.4M
Q4 24
$49.4M
Q3 24
$49.4M
Q2 24
$49.3M
Q1 24
$49.3M
Stockholders' Equity
BSRR
BSRR
DTIL
DTIL
Q4 25
$364.9M
$92.2M
Q3 25
$360.1M
$16.6M
Q2 25
$355.7M
$34.1M
Q1 25
$351.8M
$49.3M
Q4 24
$357.3M
$56.4M
Q3 24
$358.7M
$64.9M
Q2 24
$350.0M
$74.7M
Q1 24
$345.1M
$37.2M
Total Assets
BSRR
BSRR
DTIL
DTIL
Q4 25
$3.8B
$154.4M
Q3 25
$3.7B
$93.5M
Q2 25
$3.8B
$108.9M
Q1 25
$3.6B
$124.4M
Q4 24
$3.6B
$136.4M
Q3 24
$3.7B
$153.3M
Q2 24
$3.7B
$165.8M
Q1 24
$3.6B
$184.7M
Debt / Equity
BSRR
BSRR
DTIL
DTIL
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.14×
Q1 25
0.14×
Q4 24
0.14×
Q3 24
0.14×
Q2 24
0.14×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BSRR
BSRR
DTIL
DTIL
Operating Cash FlowLast quarter
$33.7M
$-11.3M
Free Cash FlowOCF − Capex
$32.2M
$-11.3M
FCF MarginFCF / Revenue
81.9%
-32.9%
Capex IntensityCapex / Revenue
3.9%
0.1%
Cash ConversionOCF / Net Profit
2.61×
-0.56×
TTM Free Cash FlowTrailing 4 quarters
$50.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BSRR
BSRR
DTIL
DTIL
Q4 25
$33.7M
$-11.3M
Q3 25
$14.9M
$-15.3M
Q2 25
$-35.9M
$-20.3M
Q1 25
$40.6M
$-19.1M
Q4 24
$57.2M
$-58.4M
Q3 24
$27.4M
$-5.9M
Q2 24
$620.0K
$-14.9M
Q1 24
$7.0M
$-19.0M
Free Cash Flow
BSRR
BSRR
DTIL
DTIL
Q4 25
$32.2M
$-11.3M
Q3 25
$14.7M
Q2 25
$-36.3M
$-20.3M
Q1 25
$40.2M
$-19.1M
Q4 24
$56.0M
$-58.7M
Q3 24
$27.3M
$-6.0M
Q2 24
$202.0K
$-14.9M
Q1 24
$6.6M
$-19.1M
FCF Margin
BSRR
BSRR
DTIL
DTIL
Q4 25
81.9%
-32.9%
Q3 25
36.7%
Q2 25
-92.6%
-112627.8%
Q1 25
109.5%
-65917.2%
Q4 24
147.9%
-9199.8%
Q3 24
70.7%
-1033.2%
Q2 24
0.5%
-29.9%
Q1 24
17.7%
-108.4%
Capex Intensity
BSRR
BSRR
DTIL
DTIL
Q4 25
3.9%
0.1%
Q3 25
0.6%
0.0%
Q2 25
1.2%
11.1%
Q1 25
1.0%
220.7%
Q4 24
3.1%
39.2%
Q3 24
0.3%
6.8%
Q2 24
1.1%
0.1%
Q1 24
1.0%
0.5%
Cash Conversion
BSRR
BSRR
DTIL
DTIL
Q4 25
2.61×
-0.56×
Q3 25
1.54×
Q2 25
-3.37×
Q1 25
4.46×
Q4 24
5.51×
Q3 24
2.58×
Q2 24
0.06×
-0.45×
Q1 24
0.75×
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons